News & Updates

Show Multimedia Only

Onradivir as good as oseltamivir for acute, uncomplicated flu

22 Jun 2025

In the treatment of adults with acute, uncomplicated influenza infections, onradivir appears to provide similar curative efficacy as oseltamivir while having an acceptable safety profile, as shown in a phase III study.

Onradivir as good as oseltamivir for acute, uncomplicated flu

22 Jun 2025

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025 by

The bispecific antibody gremubamab, which targets two proteins on the surface of Pseudomonas aeruginosa, has been shown to substantially reduce bacterial load and improve quality of life for infected bronchiectasis patients in the phase II GREAT-2 study.

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

20 Jun 2025

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025 by

The investigational influenza–COVID-19 combination vaccine mRNA-1083 has demonstrated noninferiority to recommended standard-care flu and COVID-19 vaccines, with higher immune responses and an acceptable safety profile in adults at least 50 years of age, according to the results of a phase III trial.

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

18 Jun 2025

RSV-ARI nearly triples mortality risk in new study

18 Jun 2025 by

Acute respiratory infection caused by respiratory syncytial virus (RSV-ARI) nearly triples the risk of death, particularly among individuals with chronic underlying respiratory conditions, as shown in a nationwide cohort study in Denmark.

RSV-ARI nearly triples mortality risk in new study

18 Jun 2025

Mindfulness programme may benefit COVID survivors

17 Jun 2025 by

A mindfulness-based stress reduction (MBSR) programme may improve functional and psychosocial outcomes in patients with long COVID, a study suggests.

Mindfulness programme may benefit COVID survivors

17 Jun 2025

Preconception C. trachomatis seropositivity may up risk of miscarriage

16 Jun 2025

Among women with a history of pregnancy loss, prior exposure to Chlamydia trachomatis poses an increased risk of miscarriage, as reported in a study.

Preconception C. trachomatis seropositivity may up risk of miscarriage

16 Jun 2025

Real-World Evidence in Action: Integrating data into the management of MDR Gram-negative infections

16 Jun 2025

A Pfizer-sponsored symposium held during ESCMID 2025 in Vienna, Austria explored the expanding role of real-world evidence (RWE) in managing multidrug-resistant (MDR) Gram-negative bacterial infections. The session featured three distinguished experts, Professor David van Duin from the University of North Carolina, US; Dr Paula Ramirez, an intensive care specialist at La Fe University and Polytechnic Hospital, Spain; and Professor David Paterson from the National University of Singapore, who is also the Director of ADVANCE-ID, a regional platform for infectious disease research. Together, they discussed how RWE complements traditional clinical trials, guides empirical treatment strategies, and supports the use of newer antibiotics such as ceftazidime-avibactam.

Real-World Evidence in Action: Integrating data into the management of MDR Gram-negative infections

16 Jun 2025

Lifestyle modification resolves MASLD, improves adiposity in more PLHIV than standard care

13 Jun 2025 by

Lifestyle modification induced remission of metabolic dysfunction–associated steatotic liver disease (MASLD) in a higher proportion of people living with HIV (PLHIV) than standard care, according to the first randomized controlled trial (RCT) of its kind conducted by researchers from the Chinese University of Hong Kong (CUHK).

Lifestyle modification resolves MASLD, improves adiposity in more PLHIV than standard care

13 Jun 2025

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

12 Jun 2025

At the Asia Vaccines and Antivirals Summit (AVAS) 2025 held in Bangkok, Thailand, two expert-led sessions provided valuable perspectives on the expanding role of oral antivirals in COVID-19 management. Dr Daniel Griffin, an infectious disease specialist and Clinical Instructor of Medicine at Columbia University, New York, US, focused on protecting high-risk populations through the timely use of antiviral therapy. Complementing this, Professor Ching-Tai Huang of Chang Gung University and Memorial Hospital in Taiwan offered practical guidance on clinical management strategies, including patient risk stratification and therapeutic selection.

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

12 Jun 2025

Cardiac events common among individuals hospitalized for RSV infection

05 Jun 2025 by

One in 10 individuals hospitalized for a respiratory syncytial virus (RSV) infection has a concurrent acute cardiovascular event, and this number is higher than that observed among individuals hospitalized for a COVID-19 infection, according to a study from Singapore.

Cardiac events common among individuals hospitalized for RSV infection

05 Jun 2025

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

Onradivir as good as oseltamivir for acute, uncomplicated flu

Onradivir as good as oseltamivir for acute, uncomplicated flu

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Bispecific antibody overcomes P. aeruginosa infection in patients with bronchiectasis

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

Dual-target vaccine for flu, COVID-19 compares favourably with standalone comparators

RSV-ARI nearly triples mortality risk in new study

RSV-ARI nearly triples mortality risk in new study

Mindfulness programme may benefit COVID survivors

Mindfulness programme may benefit COVID survivors

Preconception C. trachomatis seropositivity may up risk of miscarriage

Preconception C. trachomatis seropositivity may up risk of miscarriage

Real-World Evidence in Action: Integrating data into the management of MDR Gram-negative infections

Real-World Evidence in Action: Integrating data into the management of MDR Gram-negative infections

Lifestyle modification resolves MASLD, improves adiposity in more PLHIV than standard care

Lifestyle modification resolves MASLD, improves adiposity in more PLHIV than standard care

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

Protecting the vulnerable: The role of oral antivirals in COVID-19 management

Cardiac events common among individuals hospitalized for RSV infection

Cardiac events common among individuals hospitalized for RSV infection